Renishaw plc with ticker (LON:RSW) now has a potential downside of -23.9% according to Jefferies.
Jefferies set a target price of 3,270 GBX for the company, which when compared to the Renishaw plc share price of 4,296 GBX at opening today (14/06/2023) indicates a potential downside of -23.9%. Trading has ranged between 3,238 (52 week low) and 4,483 (52 week high) with an average of 47,386 shares exchanging hands daily. The market capitalisation at the time of writing is £3,064,397,955.
Renishaw plc is a United Kingdom-based company, which is engaged in designing, manufacturing, selling, distribution and service of manufacturing technologies products and services, and analytical instruments and medical devices. The Company operates through two segments: manufacturing technologies, and analytical instruments and medical devices. Manufacturing technologies segment consists of industrial metrology, position measurement and additive manufacturing (AM) product lines. Analytical instruments and medical devices segment consist of spectroscopy and neurological product lines. The Company, through its subsidiaries, manufactures some of its products and support customers in various markets of Brazil, Canada, Mexico, United States, Australia, China, Hong Kong, India, Japan, Malaysia, Singapore, South Korea, Taiwan, Austria, Czech Republic, Denmark, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, Poland, Romania, Spain, Sweden, Switzerland and Turkey.
Renishaw plc -23.9% potential downside indicated by Jefferies
[shareaholic app="share_buttons" id_name="post_below_content"]
- Written by: Charlotte Edwards
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Renishaw plc (LON:RSW) has released a trading update for the nine months ended 31 March 2024, showing solid performance and signs of semiconductor equipment recovery.
Renishaw plc has released its interim report for the six months ended December 31, 2023. Revenue decreased by 5% to £330.5m, with various factors impacting the results.